Description
OVERVIEWProduct overview
Unlike the blend, this set supplies each peptide in its own vial. Each is reconstituted separately, so concentrations can be set independently and single-peptide arms can be run alongside the combined condition.
This is the presentation most suited to a study design that needs to attribute an effect to one compound or the other.
Both compounds are supplied for laboratory research use only.
SUPPLY IN IRELANDBPC-157 and TB-500 Stack Ireland — supplied to research laboratories
Research groups across Ireland buy BPC-157 and TB-500 Stack from Kensington Laboratories as a lyophilised BPC-157 and TB-500 Stack peptide, released only against a batch-matched certificate of analysis. Every vial of high purity BPC-157 and TB-500 Stack is verified by HPLC and LC-MS before it leaves the facility, so laboratories ordering BPC-157 and TB-500 Stack in Ireland receive material with documented purity and identity.
Laboratory BPC-157 and TB-500 Stack is packed for controlled storage and sent by tracked delivery in 3–5 days to Dublin, Cork, Galway, Limerick and the rest of Ireland. Delivery costs €9.90 per order. Teams planning BPC157andTB500Stack research can review the specifications, certificate of analysis and reference list on this page before ordering.
Institutions searching for BPC-157 and TB-500 Stack peptide suppliers in Ireland typically compare purity, batch documentation and delivery times. Each of those is published here: a 99% HPLC purity specification, a certificate matched to the batch code on your vial, and tracked delivery in 3–5 days.
BPC-157 and TB-500 Stack is supplied strictly for laboratory research use only. It is not a medicine and is not for human or veterinary consumption.
SPECIFICATIONSProduct specifications
- Purity: ≥ 99% (HPLC)
- Appearance: White lyophilised powder
- Quantity: 2 × 10 mg vials per vial
- Peptide class: Two separate lyophilised vials supplied together
- Also known as: Paired vial set
- Solubility: Soluble in bacteriostatic or sterile water
- Storage temperature: Store at 2–8°C; long-term −20°C, protected from light
- Shelf life: 24 months lyophilised; 30 days reconstituted at 2–8°C
- Manufacturing standard: ISO 9001 facility, GMP-aligned solid-phase synthesis
- Batch information: Batch number and expiry printed on every vial label
RESEARCHResearch overview
The following summary is provided for educational and scientific context only. It describes what has been observed in published laboratory and animal studies and does not represent established clinical outcomes, medical advice or a claim of efficacy in humans.
Background
Unlike the blend, this set supplies each peptide in its own vial. Each is reconstituted separately, so concentrations can be set independently and single-peptide arms can be run alongside the combined condition.
This is the presentation most suited to a study design that needs to attribute an effect to one compound or the other.
Both compounds are supplied for laboratory research use only.
Current research areas
Published investigation clusters around a small number of biological themes. Each remains experimental and none has been established as a therapeutic effect in humans.
- Combined repair-pathway conditions compared against single-peptide arms
- Fibroblast activity and collagen organisation in experimental healing
- Cell migration and actin dynamics in soft tissue models
- Angiogenic signalling in wound and ischaemia models
Scientific context and proposed mechanisms
Separate vials allow independent concentration control, which matters when the two peptides are being compared rather than combined.
Reported mechanisms remain those described for each compound individually in the preclinical literature.
Interpreting the evidence
Most published work in this area uses cell culture or rodent models with small group sizes and short observation windows. Independent replication varies considerably between compounds, and results are sensitive to species, route, dose and endpoint.
There is no regulatory-approved human protocol for this compound. Any laboratory protocol should be defined by the model under study, institutional ethical approval, appropriate controls and predefined endpoints.
References
CERTIFICATE OF ANALYSISIndependent batch testing
Every released batch is independently tested. Match the batch number on the vial to the certificate published online.
- Batch number
- KL-BPC157ANDT-2405A
- Testing laboratory
- Janoshik Analytical, s.r.o.
- Date tested
- 14 May 2026
- Reported purity
- 99.09%
- Method
- RP-HPLC with UV detection at 214 nm, confirmed by LC-MS
The independent result for this batch is summarised above. Contact the laboratory team if you need the full report for this batch.
